Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Zhenduo Lu"'
Autor:
Xiuchun Chen, Zhenduo Lu, Chengzheng Wang, Minhao Lyu, Jianghua Qiao, Xianfu Sun, Lianfang Li, Chongjian Zhang, Zhenzhen Liu, Sihan Zhou, Xiuyuan Hao
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 12, Pp 1421-1430 (2024)
Abstract. Background:. Sentinel lymph node (SLN) biopsy is gradually accepted as the standard of care in breast cancer patients with down-staged axillary disease after neoadjuvant chemotherapy (NAC). However, it is still difficult to precisely define
Externí odkaz:
https://doaj.org/article/5976f92dcf344db8bb2eeb246175869a
Autor:
Chengzheng Wang, Zhenzhen Liu, Xiuchun Chen, Jianghua Qiao, Zhenduo Lu, Lianfang Li, Xianfu Sun, Chongjian Zhang, Xiayu Yue, Qingxin Xia, He Zhang, Min Yan
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-8 (2023)
Abstract Immunotherapy combined with chemotherapy has been demonstrated to be effective in early triple-negative breast cancer (TNBC). In this single-arm, phase II study with Simon’s two-stage design, we investigated the efficacy and safety of neoa
Externí odkaz:
https://doaj.org/article/1c13bb365e5d466e8ff1aba06b500817
Autor:
Min Yan, Limin Niu, Huimin Lv, Mengwei Zhang, Jing Wang, Zhenzhen Liu, Xiuchun Chen, Zhenduo Lu, Chongjian Zhang, Huiai Zeng, Shengnan Zhao, Yajing Feng, Huihui Sun, Huajun Li
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-8 (2023)
Abstract CDK4/6 inhibitors have shown a synergistic effect with anti-HER2 therapy in hormone receptor (HR)-positive and HER2-positive breast cancer (BC). In this phase 2 study (NCT04293276), we aim to evaluate a dual-oral regimen of CDK4/6 inhibitor
Externí odkaz:
https://doaj.org/article/ea84b16208d842cda6e89fa83b753bb4
Autor:
Jiujun Zhu, Dechuang Jiao, Min Yan, Xiuchun Chen, Chengzheng Wang, Zhenduo Lu, Lianfang Li, Xianfu Sun, Li Qin, Xuhui Guo, Chongjian Zhang, Jianghua Qiao, Jianbin Li, Zhimin Fan, Haibo Wang, Jianguo Zhang, Yongmei Yin, Peifen Fu, Cuizhi Geng, Feng Jin, Zefei Jiang, Shude Cui, Zhenzhen Liu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectiveAxillary node status after neoadjuvant chemotherapy (NCT) in early breast cancer patients influences the axillary surgical staging procedure. This study was conducted for the identification of the likelihood of patients being node pathologic
Externí odkaz:
https://doaj.org/article/cdff5fd3f7cb4b9fa59db1e7e1a50704
Autor:
Jiabin Wang, Jianghua Qiao, Yuxia Ruan, Chengzheng Wang, Lianfang Li, Zhenduo Lu, Xianfu Sun, Chongjian Zhang, Xiuchun Chen, Min Yan, Shude Cui, Zhenzhen Liu
Publikováno v:
Gland Surgery. 11:1887-1896
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9113c1b5239fcf7e8d4bdc28086bc5b
https://doi.org/10.21037/gs-22-632
https://doi.org/10.21037/gs-22-632
Autor:
Junzhao Wu, Minhao Lv, Peng Yuan, Youzhao Ma, Peiqi Tian, Lianfang Li, Chengzheng Wang, Zhenduo Lu, Min Yan, Xiuchun Chen, Zhenzhen Liu
Publikováno v:
Gland Surgery. 11:1341-1355
There are limited published studies on the prognostic predictors and the value of adjuvant chemotherapy (CT) in T1a,bN0M0 triple-negative breast cancer (TNBC) after local therapy. Therefore, the aim of the present study was to explore the prognostic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::848c28d463f1fa925e202bb71bb8dc4a
https://doi.org/10.21037/gs-22-409
https://doi.org/10.21037/gs-22-409
Autor:
Juntao Li, Yibing Chen, Huan Jin, Lina Wang, Jianghua Qiao, Qiming Wang, Yanjun Mi, Zhengzhi Zou, Zhenduo Lu
Publikováno v:
Biochemical and Biophysical Research Communications. 558:216-223
BET inhibitor (BETi) has potential therapeutic effects on human cancer especially in breast cancer. However, the detailed mechanisms remain unclear. Herein, we found that BETi JQ1 and I-BET-151 (I-BET) activated ATF2 through JNK1/2 pathway in breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e655a2ac8601d0e966d625020e328cd0
https://doi.org/10.1016/j.bbrc.2020.08.113
https://doi.org/10.1016/j.bbrc.2020.08.113
Autor:
Hanzhao Yang, Yadong Sun, Peili Wang, Jianghua Qiao, Lianfang Li, Zhenduo Lu, Xianfu Sun, Chongjian Zhang, Xiuchun Chen, Min Yan, Shude Cui, Chengzheng Wang, Zhenzhen Liu
Publikováno v:
Medical Science Monitor; 7/16/2023, Vol. 29, p1-9, 9p
Autor:
Jiujun Zhu, Dechuang Jiao, Chengzheng Wang, Zhenduo Lu, Xiuchun Chen, Lianfang Li, Xianfu Sun, Li Qin, Xuhui Guo, Chongjian Zhang, Jianghua Qiao, Min Yan, Shude Cui, Zhenzhen Liu
Publikováno v:
Cancers; Volume 14; Issue 18; Pages: 4508
(1) Background: The objective of our study was to provide evidence for choosing the optimal neoadjuvant therapy strategies for patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. Three neoadjuvant targeted ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81d000cfa4ba964ed2b6e1b528f6e69a
https://pubmed.ncbi.nlm.nih.gov/36139667
https://pubmed.ncbi.nlm.nih.gov/36139667
Autor:
Ping Chen, Zhenzhen Liu, Lina Wang, Jingyang Zhang, Dechuang Jiao, Zhenduo Lu, Jiujun Zhu, Jianghua Qiao, Xuhui Guo
Publikováno v:
Journal of Cellular and Molecular Medicine
Recent reports showed that haematological and neurological expressed 1‐like (HN1L) gene participated in tumorigenesis and tumour invasion. However, the expression and role of HN1L in breast cancer remain to be investigated. Here, bioinformatics, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3689a2f28a1d1e1b32a3eb17add8523
http://europepmc.org/articles/PMC7810958
http://europepmc.org/articles/PMC7810958